Mahkam Zanganeh's most recent trade in Pulse Biosciences Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 11, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2026 | 14,504 | 14,504 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2025 | 24,134 | 24,134 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 24 Jan 2025 | 30,121 | 0 | - | - | Warrant (right to buy) | ||
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 24 Jan 2025 | 30,121 | 0 | - | - | Warrant (right to buy) | ||
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 24 Jan 2025 | 30,121 | 695,274 (3%) | 0% | 11 | 331,331 | Common Stock | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 24 Jan 2025 | 30,121 | 725,395 (3%) | 0% | 11 | 331,331 | Common Stock | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2024 | 200,000 | 200,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 03 Jul 2024 | 60,242 | 665,153 (3%) | 0% | - | Common Stock | ||
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jul 2024 | 30,121 | 30,121 | - | - | Warrant (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 03 Jul 2024 | 30,121 | 30,121 | - | - | Warrant (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 8,247 | 8,247 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 09 Jun 2023 | 86,668 | 0 | - | - | Warrant (right to buy) | ||
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 09 Jun 2023 | 86,668 | 528,836 (2%) | 0% | 2.0 | 177,669 | Common Stock | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 20,168 | 20,168 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 May 2023 | 20,000 | 20,000 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 09 Jun 2022 | 86,668 | 86,668 | - | - | Warrant (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | 09 Jun 2022 | 86,668 | 442,168 (2%) | 0% | - | Common Stock | ||
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 56,075 | 56,075 | - | - | Stock Option (right to buy) | |
| Pulse Biosciences Inc | Mahkam Zanganeh | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 20,000 | 20,000 | - | - | Stock Option (right to buy) |